Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
47.55
-2.55 (-5.09%)
Mar 9, 2026, 2:51 PM CET

STO:IBT.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Other Revenue
-00.080.01-
Upgrade
Revenue
-00.080.01-
Upgrade
Revenue Growth (YoY)
--94.80%541.67%--
Upgrade
Gross Profit
-00.080.01-
Upgrade
Selling, General & Admin
20.1520.3514.581.021.12
Upgrade
Research & Development
48.85125120.1264.843.56
Upgrade
Operating Expenses
69145.35134.6965.8244.67
Upgrade
Operating Income
-69-145.34-134.62-65.81-44.67
Upgrade
Interest Expense
----0.29-0.41
Upgrade
Interest & Investment Income
3.838.4411.550.65-
Upgrade
Other Non Operating Income (Expenses)
----0.09
Upgrade
Pretax Income
-65.17-136.91-123.07-65.45-44.99
Upgrade
Net Income
-65.17-136.91-123.07-65.45-44.99
Upgrade
Net Income to Common
-65.17-136.91-123.07-65.45-44.99
Upgrade
Shares Outstanding (Basic)
1313121111
Upgrade
Shares Outstanding (Diluted)
1313121111
Upgrade
Shares Change (YoY)
-8.95%10.14%--
Upgrade
EPS (Basic)
-4.84-10.16-9.95-5.83-4.01
Upgrade
EPS (Diluted)
-4.84-10.16-9.95-5.83-4.01
Upgrade
Free Cash Flow
-72.34-113.13-101.22-85.8-55.62
Upgrade
Free Cash Flow Per Share
-5.37-8.40-8.19-7.64-4.96
Upgrade
Gross Margin
-100.00%100.00%100.00%-
Upgrade
Operating Margin
--3633575.00%-174827.27%-548400.00%-
Upgrade
Profit Margin
--3422625.00%-159828.57%-545425.00%-
Upgrade
Free Cash Flow Margin
--2828325.00%-131453.25%-714958.33%-
Upgrade
EBIT
-69-145.34-134.62-65.81-44.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.